Ruian Xu

3.1k total citations
80 papers, 2.5k citations indexed

About

Ruian Xu is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Ruian Xu has authored 80 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 31 papers in Genetics and 9 papers in Oncology. Recurrent topics in Ruian Xu's work include Virus-based gene therapy research (28 papers), RNA Interference and Gene Delivery (15 papers) and Cancer Research and Treatments (6 papers). Ruian Xu is often cited by papers focused on Virus-based gene therapy research (28 papers), RNA Interference and Gene Delivery (15 papers) and Cancer Research and Treatments (6 papers). Ruian Xu collaborates with scholars based in China, Hong Kong and United States. Ruian Xu's co-authors include Matthew J. During, Mingqing Tang, William Xu, Deborah Young, Jun Lin, Dexian Zheng, Helen L. Fitzsimons, Paola Leone, Farzin Farzaneh and Zhenjing Zhuang and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nature Medicine.

In The Last Decade

Ruian Xu

77 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruian Xu China 30 1.4k 622 380 308 240 80 2.5k
Kwang Youl Lee South Korea 29 2.3k 1.6× 315 0.5× 304 0.8× 432 1.4× 248 1.0× 101 3.5k
Mike A. Clark United States 29 1.3k 0.9× 614 1.0× 503 1.3× 291 0.9× 121 0.5× 58 2.7k
Sherif M. Karam United Arab Emirates 31 1.5k 1.0× 741 1.2× 180 0.5× 718 2.3× 154 0.6× 72 3.4k
Mi‐Young Son South Korea 30 1.8k 1.3× 239 0.4× 281 0.7× 459 1.5× 166 0.7× 122 2.9k
Wei Yu China 36 3.2k 2.2× 713 1.1× 305 0.8× 352 1.1× 280 1.2× 104 4.0k
Young Il Yeom South Korea 36 3.0k 2.1× 662 1.1× 848 2.2× 585 1.9× 180 0.8× 99 4.2k
Robert M. Umek United States 15 2.3k 1.6× 411 0.7× 333 0.9× 375 1.2× 464 1.9× 21 3.3k
T. Motyl Poland 28 1.3k 0.9× 351 0.6× 397 1.0× 539 1.8× 315 1.3× 134 2.4k

Countries citing papers authored by Ruian Xu

Since Specialization
Citations

This map shows the geographic impact of Ruian Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruian Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruian Xu more than expected).

Fields of papers citing papers by Ruian Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruian Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruian Xu. The network helps show where Ruian Xu may publish in the future.

Co-authorship network of co-authors of Ruian Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Ruian Xu. A scholar is included among the top collaborators of Ruian Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruian Xu. Ruian Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tang, Fei, et al.. (2021). Anti-HBV Activities of Polysaccharides from Thais clavigera (Küster) by In Vitro and In Vivo Study. Marine Drugs. 19(4). 195–195. 7 indexed citations
2.
3.
Tang, Mingqing, et al.. (2021). Novel Ferrocene Derivatives Induce G0/G1 Cell Cycle Arrest and Apoptosis through the Mitochondrial Pathway in Human Hepatocellular Carcinoma. International Journal of Molecular Sciences. 22(6). 3097–3097. 11 indexed citations
4.
Jiang, Nan, et al.. (2020). AHR is a tunable knob that controls HTLV-1 latency-reactivation switching. PLoS Pathogens. 16(7). e1008664–e1008664. 11 indexed citations
5.
Zhao, Jianguo, et al.. (2020). Recombinant Adeno-associated Virus 9-mediated Expression of Kallistatin Suppresses Lung Tumor Growth in Mice. Current Gene Therapy. 21(1). 72–80. 4 indexed citations
6.
Xu, Ruian, et al.. (2017). The strategies of targeting therapy of hepatocellular carcinoma by adeno-associated virus. Yaoxue xuebao. 1359–1365. 1 indexed citations
7.
Sun, Aijing, Jun Lin, Chao Pi, Ruian Xu, & Xiuling Cui. (2016). Biological Evaluation of Ferrocenyl Olefins: Cancer Cell Growth Inhibition, ROS Production, and Apoptosis Activity. Archiv der Pharmazie. 349(3). 186–192. 8 indexed citations
8.
Wang, Mingxi, et al.. (2015). Calcium-ion-modulated ceramic hydroxyapatite resin for the scalable purification of recombinant Adeno-Associated Virus serotype 9. Journal of Chromatography B. 990. 15–22. 6 indexed citations
9.
Xu, Ruian. (2009). Preparation,Purification and Activity of Recombinant Rat Cytoglobin. 1 indexed citations
10.
Jiang, Xian, Hali Li, Haiquan Qiao, et al.. (2009). Combining kallistatin gene therapy and meloxicam to treat hepatocellular carcinoma in mice. Cancer Science. 100(11). 2226–2233. 21 indexed citations
11.
Leung, Carly, et al.. (2008). Suppression of Lung Tumor Growth and Metastasis in Mice by Adeno-Associated Virus-Mediated Expression of Vasostatin. Clinical Cancer Research. 14(3). 939–949. 51 indexed citations
12.
Li, Hua, Xinyan Li, Karen S.L. Lam, et al.. (2008). Adeno-associated virus-mediated pancreatic and duodenal homeobox gene-1 expression enhanced differentiation of hepatic oval stem cells to insulin-producing cells in diabetic rats. Journal of Biomedical Science. 15(4). 487–497. 14 indexed citations
13.
Wang, Qi, Ying Lv, Yong Diao, & Ruian Xu. (2008). The Design of Vectors for RNAi Delivery System. Current Pharmaceutical Design. 14(13). 1327–1340. 14 indexed citations
14.
Li, Xinyan, et al.. (2007). Adeno-associated virus-mediated pancreatic and duodenal homeobox gene 1 delivery induced insulin-producing cells in livers of diabetic rats. Zhongguo linchuang yaolixue yu zhiliaoxue. 12(6). 614–619. 1 indexed citations
15.
Shi, Juan, Yanxin Liu, Yong Zheng, et al.. (2006). Therapeutic Expression of an Anti-Death Receptor 5 Single-Chain Fixed-Variable Region Prevents Tumor Growth in Mice. Cancer Research. 66(24). 11946–11953. 22 indexed citations
16.
Shi, Juan, Dexian Zheng, Yanxin Liu, et al.. (2005). Overexpression of Soluble TRAIL Induces Apoptosis in Human Lung Adenocarcinoma and Inhibits Growth of Tumor Xenografts in Nude Mice. Cancer Research. 65(5). 1687–1692. 109 indexed citations
17.
Ma, Hong, Yanxin Liu, Shilian Liu, Ruian Xu, & Dexian Zheng. (2005). Oral adeno‐associated virus‐sTRAIL gene therapy suppresses human hepatocellular carcinoma growth in mice†. Hepatology. 42(6). 1355–1363. 31 indexed citations
18.
Tu, Shui Ping, Jian Cui, Peter Liston, et al.. (2005). Gene therapy for colon cancer by adeno-associated viral vector-mediated transfer of survivin Cys84Ala mutant. Gastroenterology. 128(2). 361–375. 72 indexed citations
19.
Sun, Xueying, et al.. (2004). Anti-angiogenic therapy subsequent to adeno-associated-virus-mediated immunotherapy eradicates lymphomas that disseminate to the liver. International Journal of Cancer. 113(4). 670–677. 16 indexed citations
20.
Ma, Hsu, et al.. (2003). Gene Transfer into Human Keloid Tissue with Adeno-Associated Virus Vector. The Journal of Trauma: Injury, Infection, and Critical Care. 54(3). 569–573. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kwang Youl Lee Breakdown of academic impact, for papers by Mike A. Clark Breakdown of academic impact, for papers by Sherif M. Karam Breakdown of academic impact, for papers by Mi‐Young Son Breakdown of academic impact, for papers by Wei Yu Breakdown of academic impact, for papers by Young Il Yeom Breakdown of academic impact, for papers by Robert M. Umek Breakdown of academic impact, for papers by T. Motyl
Rankless by CCL
2026